These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31023435)

  • 1. Long-Term Cardiovascular Risks Associated With Adverse Pregnancy Outcomes: JACC Review Topic of the Week.
    Lane-Cordova AD; Khan SS; Grobman WA; Greenland P; Shah SJ
    J Am Coll Cardiol; 2019 Apr; 73(16):2106-2116. PubMed ID: 31023435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term sequelae of adverse pregnancy outcomes.
    Torosyan N; Aziz D; Quesada O
    Maturitas; 2022 Nov; 165():1-7. PubMed ID: 35816901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal cardiovascular impairment in pregnancies complicated by severe fetal growth restriction.
    Melchiorre K; Sutherland GR; Liberati M; Thilaganathan B
    Hypertension; 2012 Aug; 60(2):437-43. PubMed ID: 22733460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association.
    Parikh NI; Gonzalez JM; Anderson CAM; Judd SE; Rexrode KM; Hlatky MA; Gunderson EP; Stuart JJ; Vaidya D;
    Circulation; 2021 May; 143(18):e902-e916. PubMed ID: 33779213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental findings in non-hypertensive term pregnancies and association with future adverse pregnancy outcomes: a cohort study.
    Hauspurg A; Redman EK; Assibey-Mensah V; Tony Parks W; Jeyabalan A; Roberts JM; Catov JM
    Placenta; 2018 Dec; 74():14-19. PubMed ID: 30594310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-eclampsia and Cardiovascular Disease Risk Assessment in Women.
    Murphy MS; Smith GN
    Am J Perinatol; 2016 Jul; 33(8):723-31. PubMed ID: 27031056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of Cardiovascular Risk Associated with Pregnancy.
    Quesada O; Scantlebury DC; Briller JE; Michos ED; Aggarwal NR
    Curr Cardiol Rep; 2023 Feb; 25(2):77-87. PubMed ID: 36745273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental abruption and long-term maternal cardiovascular disease mortality: a population-based registry study in Norway and Sweden.
    DeRoo L; Skjærven R; Wilcox A; Klungsøyr K; Wikström AK; Morken NH; Cnattingius S
    Eur J Epidemiol; 2016 May; 31(5):501-11. PubMed ID: 26177801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes: A Review.
    Jowell AR; Sarma AA; Gulati M; Michos ED; Vaught AJ; Natarajan P; Powe CE; Honigberg MC
    JAMA Cardiol; 2022 Mar; 7(3):346-355. PubMed ID: 34705020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy as a window to future health: maternal placental syndromes and short-term cardiovascular outcomes.
    Cain MA; Salemi JL; Tanner JP; Kirby RS; Salihu HM; Louis JM
    Am J Obstet Gynecol; 2016 Oct; 215(4):484.e1-484.e14. PubMed ID: 27263996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the link between the placenta and future cardiovascular disease.
    Siddiqui N; Hladunewich M
    Trends Cardiovasc Med; 2011 Oct; 21(7):188-93. PubMed ID: 22867697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse pregnancy outcomes and future risk of heart failure.
    Pabón MA; Misra A; Honigberg MC
    Curr Opin Cardiol; 2023 May; 38(3):215-222. PubMed ID: 36927985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preeclampsia and future cardiovascular risk.
    Newstead J; von Dadelszen P; Magee LA
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):283-94. PubMed ID: 17338672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in Awareness of Association Between Adverse Pregnancy Outcomes and Cardiovascular Risk by Specialty.
    Gogineni VSM; Manfrini D; Aroda SH; Zhang Y; Nelson DS; Egerman R; Park K
    Cardiol Ther; 2021 Dec; 10(2):577-592. PubMed ID: 34043209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Adding Adverse Pregnancy Outcomes Improve the Framingham Cardiovascular Risk Score in Women? Data from the Tehran Lipid and Glucose Study.
    Saei Ghare Naz M; Sheidaei A; Aflatounian A; Azizi F; Ramezani Tehrani F
    J Am Heart Assoc; 2022 Jan; 11(2):e022349. PubMed ID: 35016530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The recurrence risk of adverse outcome in the second pregnancy in women with rheumatic disease1.
    Skomsvoll JF; Baste V; Irgens LM; Østensen M
    Obstet Gynecol; 2002 Dec; 100(6):1196-202. PubMed ID: 12468163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease.
    Wu P; Park K; Gulati M
    Eur Cardiol; 2021 Feb; 16():e31. PubMed ID: 34603511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term renal and cardiovascular risk after preeclampsia: towards screening and prevention.
    Paauw ND; Luijken K; Franx A; Verhaar MC; Lely AT
    Clin Sci (Lond); 2016 Feb; 130(4):239-46. PubMed ID: 26769659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do pregnancy complications and CVD share common antecedents?
    Sattar N
    Atheroscler Suppl; 2004 May; 5(2):3-7. PubMed ID: 15121029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.